“…miR-139-5p was reported to inhibit tumorigenesis and reverses drug resistance in many cancers (Wang et al , 2017 ; Jiang et al , 2018 ; Zhang et al , 2018 ). Targets of miR-139-5p , such as c-Jun (Jiang et al , 2018 ; Su et al , 2018 ), PI3K/Akt (Maoa et al , 2015 ; Catanzaro et al , 2018 ), IGF-1/IGF-1R (Xu et al , 2015 ), VEGF, and Wnt/β-catenin (Long et al , 2017 ; Xie and Shen, 2018 ), are potent stimulators of cell proliferation, some of which are important pathways promoting injury repair (Zhou et al , 2016 ; Guise and Chade, 2018 ; Xie et al , 2018 ). Therefore, we postulate that the downregulation of miR-139-5p may reflect an activation of cell proliferation, promoting the repair and regeneration of injured kidney.…”